TRANSMISSION PREVENTION OF VIRUSES WITH APPLICATION OF ANTISEPTIC COMPOSITION

    公开(公告)号:US20220288108A1

    公开(公告)日:2022-09-15

    申请号:US17633377

    申请日:2020-08-28

    Abstract: Aspects of the present disclosure relate to a method of preventing transmission of an enveloped RNA virus. The method includes applying to a mucosal tissue of a first mammalian subject not substantially colonized by the enveloped RNA virus an effective amount of an antiseptic composition or a pharmaceutically acceptable salt thereof according to a treatment plan. The first mammalian subject not substantially colonized by the enveloped RNA virus interacts with a second mammalian subject colonized by the enveloped RNA virus at a first viral load, the first mammalian subject has a second viral load based on the interaction, the second viral load is no greater than 0.5 log increase over an initial viral load over a duration of the treatment plan. The mucosal tissue is in the nasopharynx, nasal cavity, or anterior nares of the mammalian subject. The antiseptic composition comprises iodine, iodophor, or combinations thereof.

    THERAPEUTIC COMPOSITION AND RELATED METHODS

    公开(公告)号:US20220030860A1

    公开(公告)日:2022-02-03

    申请号:US17263663

    申请日:2019-08-05

    Abstract: A composition. The composition includes a compound of Formula (I) HOCH2—(═CHOH═)n—CH2NR1R2 (I) wherein R1 and R2 are independently selected from the group consisting of a hydrogen atom, an alkyl group, C(O)R3, and SO2R4, wherein at least one of R1 and R2 is C(O)R3 or SO2R4, R3 and R4 are selected from the group consisting of an alkyl group having seven carbon atoms, an alkyl group having eight carbon atoms, and an alkyl group having nine carbon atoms, and n is an integer from about 2 to about wherein a concentration of the compound of Formula (I) is more than its critical micelle concentration; and an antimicrobial agent selected from the group consisting of a biguanide antimicrobial agent and a polymeric, cationic, non-micelle forming antimicrobial material; wherein a concentration of the antimicrobial agent is no more than 5 wt %.

Patent Agency Ranking